0001209191-19-035061.txt : 20190606 0001209191-19-035061.hdr.sgml : 20190606 20190606161936 ACCESSION NUMBER: 0001209191-19-035061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190605 FILED AS OF DATE: 20190606 DATE AS OF CHANGE: 20190606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIEBERBURG IVAN M CENTRAL INDEX KEY: 0001266427 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 19882821 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL, SUITE 320 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-05 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001266427 LIEBERBURG IVAN M C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 1 0 0 0 Stock Option (Right to Buy) 4.80 2019-06-05 4 A 0 10000 0.00 A 2029-06-04 Common Stock 10000 10000 D The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 5, 2019, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date. /s/ Alfred Merriweather, Attorney-in-fact 2019-06-06